TARDBP and amyotrophic lateral sclerosis: Our study is the first to provide both mRNA and miRNA expression profiles with integrated mRNA/miRNA analyses, with the aim of increasing our understanding of TDP-43 pathobiology in ALS and identifying molecules able to restore disease-relevant phenotypes.